MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/strokeaha.122.039277

Медицинская библиотека · Stroke · 2022

Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population.

Yao Dongxiao, Li Shan, Jing Jing, Cai Xueli, Jin Aoming, Yang Yingying, Wang Suying, Meng Xia, Lin Jinxi, Mei Lerong, Li Hao, Wei Tiemin, Wang Yongjun, Pan Yuesong, Wang Yilong

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The aim of this study was to investigate the relationship between serum cystatin C levels and the presence and severity of cerebral small vessel disease (CSVD).

METHODS

Community-dwelling residents in the Lishui city in China from the cross-sectional survey of the PRECISE (Poly-Vascular Evaluation for Cognitive Impairment and Vascular Events) cohort study were included in present study from 2017 to 2019. Total CSVD burden and modified total CSVD burden score, as well as the markers of CSVD on magnetic resonance imaging, including white matter hyperintensity, lacunes, cerebral microbleeds, and perivascular spaces, were assessed at baseline survey. Participants were divided into 4 groups according to the quartiles of cystatin C. The association of serum cystatin C with total CSVD burden and imaging markers was analyzed using ordinal or binary logistic regression models. Furthermore, 2-sample Mendelian randomization analysis was performed to investigate the genetically predicted effect of cystatin C on CSVD.

RESULTS

A total of 3061 participants were included in this study. The mean age of the participants was 61.2±6.7 years, and 1637 (53.5%) were women. Higher level of cystatin C was associated with an increased total CSVD burden and modified total CSVD burden (Q4 versus Q1: common odds ratio [OR], 1.30 [95% CI, 1.03-1.64] and 1.32 [95% CI, 1.01-1.73]) after adjustment for covariates. Further, compared with the first quartile of cystatin C, subjects in the last quartile had higher risk of lacunes (OR, 1.99 [95% CI, 1.05-3.76]), modified white matter hyperintensity burden (common OR, 1.42 [95% CI, 1.07-1.90]), and moderate-to-severe perivascular spaces (OR, 2.15 [95% CI, 1.29-3.59]) but not cerebral microbleeds. The Mendelian randomization analysis showed that a genetically predicted higher cystatin C level was associated with increased risk of lacunar stroke (OR, 1.16 [95% CI, 1.06-1.27]).

CONCLUSIONS

In this community-based study, we found a possible association between cystatin C and CSVD, especially for lacunes, that was independent of estimated glomerular filtration rate.

Для цитирования: Yao Dongxiao, Li Shan, Jing Jing, Cai Xueli, Jin Aoming, Yang Yingying, Wang Suying, Meng Xia, Lin Jinxi, Mei Lerong, Li Hao, Wei Tiemin, Wang Yongjun, Pan Yuesong, Wang Yilong. Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population.. Stroke. 2022. DOI: 10.1161/strokeaha.122.039277.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.